Petros Pharmaceuticals Inc Ordinary Shares PTPI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
-
Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
-
Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Trading Information
- Previous Close Price
- $0.35
- Day Range
- $0.35–0.36
- 52-Week Range
- $0.28–2.27
- Bid/Ask
- $0.35 / $0.37
- Market Cap
- $3.41 Mil
- Volume/Avg
- 41,305 / 238,482
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.33
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 21
- Website
- https://www.petrospharma.com
Valuation
|
Metric
|
PTPI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.41 |
Price/Sales | 0.33 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PTPI
|
|---|---|
Quick Ratio | 0.93 |
Current Ratio | 1.40 |
Interest Coverage | −14.70 |
Quick Ratio
PTPI
Profitability
|
Metric
|
PTPI
|
|---|---|
Return on Assets (Normalized) | −83.86% |
Return on Equity (Normalized) | −263.56% |
Return on Invested Capital (Normalized) | −141.06% |
Return on Assets
PTPI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Ngxyjpbhv | Xsgnp | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Yfslrgkp | Xcvyfsh | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Bsnmhygj | Cvvg | $45.9 Bil | |||
| Viatris Inc
VTRS
| Rdyvrjjgv | Ngvzw | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bgtmlrmys | Mtnn | $13.2 Bil | |||
| Catalent Inc
CTLT
| Zptkwsds | Dftcx | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Htkhhgllz | Yzyrqmt | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Mvhwngylp | Vdjkh | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Zbtfpfyrj | Vlh | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Qxsbcdjj | Xhdz | $2.2 Bil |
United States